今日药学

2002, (05) 52-53

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Archive) | 高级检索(Advanced Search)

干扰素及拉米夫定治疗慢性乙肝成本-效果比较
Comparing the effect and economic effectiveness of Interferon alfa-1b and Lamivudine in treating chronic hepatitis B

何红,余干林
He Hong ;Yu Ganlin (Dept.of Pharmary;

摘要(Abstract):

目的 对比干扰素与拉米夫定治疗慢性乙肝的疗效及经济效果。方法 将 10 6例患者随机分为 2组。一组应用干扰素α 1b治疗 (6 0例 ) ,另一组应用拉米夫定治疗 (4 6例 )。统计分析两组的疗效并进行经济学分析。结果与结论 两组药物均能有效治疗慢性乙肝 ,干扰素疗效稍好 ,拉米夫定费用较低
Objective To compare the effect and economic effectiveness of interferon alfa-1b and lamivudine in treating chronic hepatitis B.Methods 106 patients with impotence were divided into two groups.The patients in the first group (60 cases) were treated with interferon alfa-1b.The patients in the second groud (46 cases) were treated with lamivudine. Results &Conclusion: Both therapeutic schemes were effective in treating chronic hepatitis B.Interferon alfa-1b was slightly better.Lamivudine is cheaper.

关键词(KeyWords): 干扰素α-1b;拉米夫定;慢性乙肝;药物经济学
interferon alfa-1b;lamivudine;chronic hepatitis B

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 何红,余干林
He Hong ;Yu Ganlin (Dept.of Pharmary;

扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享